Form 4: LeMaitre Vascular Director Acquires Shares Through Performance Share Unit Settlement

Director Lawrence J. Jasinski acquired 204 shares of LeMaitre Vascular common stock on February 28, 2025, through the settlement of a Performance Share Unit (PSU) award.

Summary

• On February 28, 2025, Lawrence J. Jasinski, a director of LeMaitre Vascular, Inc., acquired 204 shares of common stock due to the settlement of a Performance Share Unit (PSU) award granted on December 8, 2023.
• Additionally, Mr. Jasinski acquired 1 share upon the release of dividend equivalent rights.
• The price for both transactions was $0.
• Following these transactions, Mr. Jasinski directly owns 5,749 shares of LeMaitre Vascular common stock.
• A Power of Attorney was granted on December 11, 2024, authorizing certain individuals to execute SEC filings on behalf of Lawrence J. Jasinski.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting required information about stock transactions. The acquisition of shares by a director is generally viewed as a slightly positive sign, but it's a routine event.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document does not contain specific forward-looking statements regarding the company's future performance, but it details the vesting schedule of a PSU award, which implies continued alignment of executive compensation with company performance.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency regarding the ownership of company stock by its directors.

Comparison to Industry Standards

• Tracking insider transactions is a standard practice in financial analysis to gauge management's sentiment and alignment with shareholder interests.
• Companies like Medtronic, Boston Scientific, and Abbott also have similar insider transaction disclosures.
• The vesting schedule of the PSU award is a common compensation mechanism used to incentivize long-term performance, similar to practices observed in comparable medical device companies.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it signals confidence from a company director.
• The vesting of PSU awards aligns management's interests with those of shareholders.

Key Dates